Zobrazeno 1 - 10
of 127
pro vyhledávání: '"F. L. Douglas"'
Autor:
F. L. Douglas, H. P. Dustan, Martha N. Hill, S. Steigerwalt, Louis R. Caplan, C. L. Curry, W. Frishman, Reginald L. Washington, N. B. Shulman, A. C. De Leon
Publikováno v:
Circulation. 85(2)
Publikováno v:
Pharmaceutical research. 9(2)
Very little information is available on the permeability of the blood-brain barrier (BBB) to small polar drugs in chronic hypertension. The blood and cerebrospinal fluid (CSF) pharmacokinetics of libenzapril (LZP), a potent angiotensin converting enz
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 19(5)
Using isolated rat hepatocytes, the in vitro intrinsic hepatic clearance of three drugs, namely, antipyrine (AP), propranolol (P), and CGS 13429 was determined. The hepatic extraction ratios of AP, P, and CGS 13429 were then calculated to be 0.10, 0.
Autor:
K. H. Antonin, Michael H. Schwenk, F L Douglas, P Etienne, P. R. Bieck, B. Mühlbauer, W M Coram
Publikováno v:
European journal of clinical pharmacology. 40(4)
Autor:
A, Rakhit, S K, Kuwahara, D R, Jones, V F, Soliman, A N, Kotake, T D, Oglesby, J W, Wasley, S L, Tripp, F L, Douglas
Publikováno v:
Pharmaceutical research. 7(10)
The o-naphthoquinone derivative, CGS 8515 (I), is a potent inhibitor (IC50, 0.1 microM) of 5-lipoxygenase, but its therapeutic potential is compromised by a short plasma half-life (22 min) and extremely poor oral bioavailability (less than 2%). Poor
Publikováno v:
The American journal of clinical nutrition. 51(4)
The effect of magnesium supplementation on blood pressure, erythrocyte cation metabolism, and serum lipids was evaluated in 13 patients with mild hypertension. After randomization and a 3-wk placebo run-in period, seven patients received 40 mmol Mg a
Autor:
T. A. Burke, A V Schaffer, J Peppard, T Viswanathan, F L Douglas, Young D. Kim, J S Fomsgaard, M.R Danchak, Adam K. Myers
Publikováno v:
Anesthesia & Analgesia. 74:38
Neutralization of heparin anticoagulation by protamine produces catastrophic hemodynamic reactions in some patients. Using a canine model, we tested effects of thromboxane synthetase inhibition (CGS-13080) and glucocorticoid pretreatment on the cardi
Publikováno v:
Hypertension. 8:298-302
Agonists of dopamine receptors can lower blood pressure by vasodilation through action on dopamine1 receptors, inhibition of sympathetic nerve activity by action on dopamine2 receptors, or actions in the central nervous system. Fenoldopam, a selectiv
Publikováno v:
Circulation. 76:1312-1318
Activation of dopamine1 (DA1) receptors relaxes vascular smooth muscle, especially in the renal vascular bed. Fenoldopam, the first selective DA1-receptor agonist that can be administered to man, was infused intravenously in 17 patients with essentia
Autor:
Tadić, Zoran1 t.albolabris@gmail.com
Publikováno v:
Comparative Cognition & Behavior Reviews. 2023, Vol. 18, p95-120. 26p.